Skip to content
lsd.com
CompletedN/A

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

NCT04057989 · Defense and Veterans Center for Integrative Pain Management

Closed to entry
Status
Not accepting participants
Not applicable
Phase
80
Target enrolment
1
Study sites
1 US states

What it is testing

Summary

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Opioid consumption measured in morphine equivalents

    Measured over 24 hours before ketamine infusion

  • Opioid consumption measured in morphine equivalents

    Measured over 24 hours after ketamine infusion

  • Opioid consumption measured in morphine equivalents

    Measured over 48 hours after ketamine infusion

  • Pain scores

    Measured over 24 hours before ketamine infusion

  • Pain scores

    Measured over 24 hours after ketamine infusion

  • Pain scores

    Measured over 48 hours after ketamine infusion

  • Number of ketamine side effects

    Measured over 24 hours before ketamine infusion

  • Number of ketamine side effects

    Measured over 24 after ketamine infusion

  • Number of ketamine side effects

    Measured over 48 hours after ketamine infusion

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Battlefield injured from January 2007 to December 2013 * Prescribed a ketamine infusion for acute pain * Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion Exclusion Criteria: * Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff * No continuous perineural catheter or epidural placement while on ketamine infusion * Less than 18 years old

Where

1 study site

FacilityCityRegionCountry
Walter Reed National Military Medical CenterBethesdaMarylandUnited States

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT04057989 on ClinicalTrials.gov →

Last updated in the registry 2019-08-15. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Recruiting in